Cart
sales@molnova.com
Nafoxidine
CAS No. 1845-11-0
Nafoxidine( —— )
Catalog No. M27396 CAS No. 1845-11-0
Nafoxidine is an estrogen antagonist that has been used in the treatment of breast cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 43 | In Stock |
|
| 5MG | 34 | In Stock |
|
| 10MG | 50 | In Stock |
|
| 25MG | 93 | In Stock |
|
| 50MG | 144 | In Stock |
|
| 100MG | 231 | In Stock |
|
| 200MG | 342 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNafoxidine
-
NoteResearch use only, not for human use.
-
Brief DescriptionNafoxidine is an estrogen antagonist that has been used in the treatment of breast cancer.
-
DescriptionNafoxidine is an estrogen antagonist that has been used in the treatment of breast cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetEstrogen Receptor/ERR
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1845-11-0
-
Formula Weight425.572
-
Molecular FormulaC29H31NO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1ccc2C(=C(CCc2c1)c1ccccc1)c1ccc(OCCN2CCCC2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Siqin Zhaorigetu, et al. Perturbations in Endothelial Dysfunction-Associated Pathways in the Nitrofen-Induced Congenital Diaphragmatic Hernia Model. J Vasc Res. 2018;55(1):26-34.
molnova catalog
related products
-
Palazestrant
Palazestrant (OP-1250) is an orally available and highly potent estrogen receptor antagonist and selective ER degrader with antitumor activity.
-
Norethindrone
Norethindrone is a synthetic progestin, which mimic the actions of the endogenous ovarian hormone progesterone.
-
XCT790
A potent and selective ERRα inverse agonist with IC50 of 300-500 nM in transient transfection assays.
